These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 7107364)

  • 1. In vitro and in vivo radiosensitization by 2-nitroimidazoles more electron-affinic than misonidazole.
    Brown DM; Yu NY; Brown JM; Lee WW
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):435-8. PubMed ID: 7107364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiosensitization in multifraction schedules. II. Greater sensitization by 2-nitroimidazoles than by oxygen.
    Taylor YC; Brown JM
    Radiat Res; 1987 Oct; 112(1):134-45. PubMed ID: 3659294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIH-802, an acetohydroxamic acid derivative of 2-nitroimidazole, as a new potent hypoxic cell radiosensitizer: radiosensitizing activity, acute toxicity, and pharmacokinetics.
    Sasai K; Shibamoto Y; Takahashi M; Zhou L; Hori H; Nagasawa H; Shibata T; Inayama S; Abe M
    Cancer Chemother Pharmacol; 1990; 26(2):112-6. PubMed ID: 2140730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of hypoxic cell radiosensitization and the development of new sensitizers.
    Stratford IJ
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):391-8. PubMed ID: 7050037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials of radiosensitizers: what should we expect?
    Brown JM
    Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):425-9. PubMed ID: 6231272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misonidazole and MTDQ in combination: cytotoxic and radiosensitizing properties in hypoxic mammalian cells.
    Astor M; Hall EJ
    Br J Cancer; 1979 May; 39(5):510-5. PubMed ID: 486306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azomycin riboside: a new radiosensitizer.
    Pedersen JE; Barron G; Chapman JD
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):415-8. PubMed ID: 7107360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electron affinic sensitization. V. Radiosensitization of hypoxic bacteria and mammalian cells in vitro by some nitroimidazoles and nitropyrazoles.
    Asquith JC; Watts ME; Patel K; Smithen CE; Adams GE
    Radiat Res; 1974 Oct; 60(1):108-18. PubMed ID: 10881704
    [No Abstract]   [Full Text] [Related]  

  • 9. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170).
    Murayama C; Suzuki A; Suzuki T; Miyata Y; Sakaguchi M; Tanabe Y; Tanaka N; Mori T
    Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):575-81. PubMed ID: 2528527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of X-ray-induced potentially lethal damage (PLD) repair in aerobic plateau-phase Chinese hamster cells by misonidazole.
    Brown DM; Dionet C; Brown JM
    Radiat Res; 1984 Jan; 97(1):162-70. PubMed ID: 6229806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiosensitization, pharmacokinetics, and toxicity of a 2-nitroimidazole nucleoside (RA-263).
    Agrawal KC; Rupp WD; Rockwell S
    Radiat Res; 1986 Feb; 105(2):227-39. PubMed ID: 3754053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin sensitization by misonidazole: a demonstration of uniform mild hypoxia.
    Stewart FA; Denekamp J; Randhawa VS
    Br J Cancer; 1982 Jun; 45(6):869-77. PubMed ID: 7093121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing of hypoxic cell radiosensitizers in vivo.
    Denekamp J
    Cancer Clin Trials; 1980; 3(2):139-48. PubMed ID: 7428137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU.
    Workman P; Twentyman PR
    Br J Cancer; 1982 Aug; 46(2):249-59. PubMed ID: 7150475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitization in vitro and in vivo by 3-nitrotriazoles.
    Shibamoto Y; Sakano K; Kimura R; Nishidai T; Nishimoto S; Ono K; Kagiya T; Abe M
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1063-6. PubMed ID: 3744928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new, potent 2-nitroimidazole nucleoside hypoxic cell radiosensitizer, RP170.
    Sasai K; Shibamoto Y; Takahashi M; Abe M; Wang J; Zhou L; Nishimoto S; Kagiya T
    Jpn J Cancer Res; 1989 Nov; 80(11):1113-8. PubMed ID: 2532634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanisms of cytotoxicity and chemosensitization by misonidazole and other nitroimidazoles.
    Brown JM
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):675-82. PubMed ID: 7050043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vitro sensitivity of chronically hypoxic EMT6/SF cells to X-radiation and hypoxic cell radiosensitizers.
    Shrieve DC; Harris JW
    Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Jul; 48(1):127-38. PubMed ID: 3159699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misonidazole neurotoxicity in mice decreased by administration with pyridoxine.
    Eifel PJ; Brown DM; Lee WW; Brown JM
    Int J Radiat Oncol Biol Phys; 1983 Oct; 9(10):1513-9. PubMed ID: 6629891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo radiosensitizing effect of nitroimidazole derivative KIN-804.
    Tada T; Nakajima T; Onoyama Y; Murayama C; Mori T; Nagasawa H; Hori H; Inayama S
    Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):601-5. PubMed ID: 8005823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.